|
Variables
|
CTNND1 staining
|
Total
|
P
a
|
|---|
|
Low
|
High
|
|---|
|
Age (y)
| | | |
0.667
|
|
≤ 50
|
89 (77 %)
|
27 (23 %)
|
116
|
|
> 50
|
131 (76 %)
|
42 (24 %)
|
173
|
|
Sex
| | | |
0.262
|
|
Male
|
163 (69 %)
|
27 (31 %)
|
235
|
|
Female
|
42 (78 %)
|
12 (22 %)
|
54
|
|
HBsAg
| | | |
0.231
|
|
Negative
|
53 (65 %)
|
28 (35 %)
|
81
|
|
Positive
|
151 (73 %)
|
57 (27 %)
|
208
|
|
HCV
| | | |
0.135
|
|
Negative
|
185 (76 %)
|
57 (24 %)
|
242
|
|
Positive
|
31 (66 %)
|
16 (34 %)
|
47
|
|
AFP
| | | |
0.634
|
|
≤ 20
|
64 (69 %)
|
27 (31 %)
|
93
|
|
> 20
|
136 (68 %)
|
60 (32 %)
|
196
|
|
γ-GT(U/L)
| | | |
0.187
|
|
≤ 54
|
113 (81 %)
|
26 (19 %)
|
139
|
|
> 54
|
110 (73 %)
|
40 (27 %)
|
150
|
|
Liver cirrhosis
| | | |
0.766
|
|
No
|
41 (66 %)
|
22 (34 %)
|
62
|
|
Yes
|
159 (70 %)
|
68 (30 %)
|
227
|
|
Tumor diameter (cm)
| | | |
0.028
|
|
≤ 5
|
178 (70 %)
|
77 (30 %)
|
255
|
|
> 5
|
15 (44 %)
|
19 (56 %)
|
34
|
|
Microvascular invasion
| | | |
<0.001
|
|
Absence
|
92 (80 %)
|
23 (20 %)
|
115
|
|
Present
|
63 (36 %)
|
111 (64 %)
|
174
|
|
Tumor encapsulation
| | | |
0.196
|
|
Complete
|
83 (62 %)
|
50 (38 %)
|
133
|
|
None
|
91 (58 %)
|
65 (42 %)
|
156
|
|
Tumor differentiation
| | | |
<0.001
|
|
I + II
|
135 (71 %)
|
56 (29 %)
|
191
|
|
III + IV
|
31 (32 %)
|
67 (68 %)
|
98
|
|
TNM stage
| | | |
0.307
|
|
I
|
161 (69 %)
|
73 (31 %)
|
234
|
|
II + III
|
32 (58 %)
|
23 (42 %)
|
55
|
-
Abbreviations: HBsAg hepatitis B surface antigen; AFP α-fetoprotein; γ-GT γ-glutamyl transferase; TNM, tumor-nodesmetastasis
-
a
p-value < 0.05 was considered statistically significant. p-values were calculated using the Pearson chi-square test
